<p>Four biopharmaceutical industry CEOs and company cofounders converse on what their organizations are doing to spur the development of diagnostic tests, therapeutics, and vaccines in order to turn the tide on the COVID-19 pandemic.</p>

Four biopharmaceutical industry CEOs and company cofounders converse on what their organizations are doing to spur the development of diagnostic tests, therapeutics, and vaccines in order to turn the tide on the COVID-19 pandemic.

Special Edition #4: What's Happening On The Front Lines of COVID-19: A CEO Roundtable On Technologies In Development For The Current Pandemic

Life Science Connect Editorial Director, Dan Schell, works with a talented and passionate group of editors. Each week, he sits down with them to discuss their pressing coverage areas, latest travels, and interesting interviews from within the life sciences landscape. His rotating cast of contributors includes Life Science Connect editors Rob Wright, Ed Miseta, Louis Garguilo, Anna Rose Welch, Erin Harris, and Matt Pillar.

Share Special Edition #4: What's Happening On The Front Lines of COVID-19: A CEO Roundtable On Technologies In Development For The Current Pandemic

Sign up to save your podcasts

Special Edition #4: What's Happening On The Front Lines of COVID-19: A CEO Roundtable On Technologies In Development For The Current Pandemic

Special Edition #4: What's Happening On The Front Lines of COVID-19: A CEO Roundtable On Technologies In Development For The Current Pandemic